The Association of California Cannabis Laboratories Announces the Establishment of a Not-for-profit Corporation
The Association of California Cannabis Laboratories announced today the formation of a not for profit corporation comprised of member laboratories operating in California. Member laboratories join together to establish best practices and industry standards for the medical marijuana industry.
Oakland California (PRWEB) February 26, 2012
The Association of California Cannabis Laboratories (ACCL) announced today that it has formalized its efforts as a not-for-profit organization in the State of California dedicated to the furtherance of quality standards and approved testing methods for medical cannabis.
“The ACCL will provide a forum for dialogue between existing labs, begin programs to establish best practices and certifications and offer suggestions as to how to communicate more broadly and effectively as integral members of the medical marijuana community” offers Dr. Robert Martin, ACCL CEO (co-founder CW Analytical).
Proposed member laboratories will be required to limit business to within the State of California and demonstrate satisfactory scientific acumen and expertise as part of the mutually agreed upon membership requirements. “Patients, growers and dispensaries should look for the ACCL logo when determining which lab to use in the future, as ACCL member laboratories will be those that represent the highest level of accuracy and dependability,” adds David Lampach, ACCL President (co-founder Steep Hill Laboratories).
“The participation of California laboratories has been outstanding and all the major players have come to the table. One of the main goals of the ACCL is to serve as an example to the rest of the industry on how to work together effectively to bring greater legitimacy and credibility to the medical marijuana community,” says Samantha Miller, ACCL Secretary President and Chief Scientist Pure Analytics).
“The ACCL seeks to establish an open forum within which scientists can discuss technical aspects pertaining to quality control of various products provided to the medical cannabis community. With broad based participation by most California laboratories, including a strong foundation comprised of industry leaders, the ACCL is poised to positively impact the quality and cleanliness of medical cannabis for all patients within California,” says Dr. Jeffrey C. Raber, ACCL CFO (co-founder The Werc Shop).
For more information, contact Dr. Robert Martin, ACCL CEO (and co-founder CW Analytical) at robert(at)cwanalytical(dot)com.
